PROVIVE

This brand name is authorized in Brazil, Ecuador, Hong Kong, Lithuania, Nigeria, New Zealand, Poland, South Africa

Active ingredients

The drug PROVIVE contains one active pharmaceutical ingredient (API):

1 Propofol UNII YI7VU623SF - PROPOFOL

Propofol (2, 6-diisopropylphenol) is a short-acting general anaesthetic agent with a rapid onset of action of approximately 30 seconds. Read about Propofol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PROVIVE Emulsion for injection	Medicines and Medical Devices Safety Authority (NZ)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N01AX10	Propofol	N Nervous system → N01 Anesthetics → N01A Anesthetics, general → N01AX Other general anesthetics
Discover more medicines within N01AX10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 533021090075217, 533021090075317, 533021090075417, 533021090075517, 533021090075617
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 500-MEE-1114
Country: HK	Department of Health Drug Office	Identifier(s): 56205
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1069923
Country: NG	Registered Drug Product Database	Identifier(s): 04-7089
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 12524, 13986
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100215418, 100215424
Country: ZA	Health Products Regulatory Authority	Identifier(s): A39/2.1/0447